HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural basis of the autolysis of AaHIV suggests a novel target recognizing model for ADAM/reprolysin family proteins.

Abstract
AaHIV, a P-III-type snake venom metalloproteinase (SVMP), consists of metalloproteinase/disintegrin/cysteine-rich (MDC) domains and is homologous to a disintegrin and metalloproteinase (ADAM) family proteins. Similar to brevilysin H6 and jararhagin, AaHIV can easily autolyse to release a stable protein named acucetin, which contains disintegrin-like and cysteine-rich domains. In this study, we determined the crystal structure of AaHIV and investigated the autolysis mechanism. Based on the structure of AaHIV and the results from docking experiments, we present a new model for target recognition in which two protein molecules form a functional unit, and the DC domain of one molecule is used for target recognition while the M-domain of the other is used for target proteolysis. Our results shed new light on the mechanism of target recognition and processing in ADAM/reprolysin family proteins.
AuthorsZhiqiang Zhu, Yongxiang Gao, Zhongliang Zhu, Yang Yu, Xiao Zhang, Jianye Zang, Maikun Teng, Liwen Niu
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 386 Issue 1 Pg. 159-64 (Aug 14 2009) ISSN: 1090-2104 [Electronic] United States
PMID19505434 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Crotalid Venoms
  • ADAM Proteins
Topics
  • ADAM Proteins (chemistry)
  • Agkistrodon
  • Amino Acid Sequence
  • Animals
  • Catalytic Domain
  • Crotalid Venoms (enzymology)
  • Hydrolysis
  • Models, Chemical
  • Molecular Sequence Data
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: